Article Correctness Is Author's Responsibility: Hydromethylthionine could slow cognitive decline: Minimum dose

Researchers have reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.